Featured Bloggers

Below are links to some of our more frequent bloggers, including their latest blog posts and other contributions:

Frederic W. Grannis, Jr., MD
Rebecca Bechhold, MD
David Eagle, MD
Craig R. Hildreth, MD
Paul R. Helft, MD
Richard Rosenbluth, MD


Recently, my treatment center changed the contrast agent patients are asked to drink prior to having a CT. They look and taste the same. So why has the switch bothered me so much?

Each person facing cancer has their own way of coping. They have no obligation to fit a stereotype that others may have conjured up. They are each the poster child of their own unique campaign.

End-of-life care is challenging for even the most seasoned oncologist. Here are five suggestions that can help you better navigate this difficult but critical part of your work.

Regardless of where you practice, good communication between you and your pathologist is the best way to ensure that correct testing is done. Here are six common points of miscommunication to watch out for.

When the media reported earlier this year that giant drugstore chain CVS had announced that it would stop selling tobacco products, it appeared to be a sudden, independent, and ethically responsible business decision. In fact, there is important background and subtext.

We can all agree that communication skills are essential to quality cancer care. Oncologists are expected to explain complex situations clearly. Be on the lookout for doctors who say any of these—it could be a sign that they need an attitude adjustment.

Is there any truth in advertising? A recent study found that cancer center ads only emphasize positive outcomes, but other than direct-to-consumer marketing of pharmaceuticals that list all possible side effects, are you aware of any ads that state less than optimal outcomes?


Subscribe to Blog on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.